However, the defining diagnostic test to differentiate between lipomas and ALT/well differentiated liposarcoma is the molecular demonstration by fluorescence in-situ hybridisation of amplification of the MDM-2 cell cycle oncogene. This evidence concerns the gene GPT and lipoma.